Youngro S. Byun
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 142 publications
An in situ immunogenicity-amplifying payload delivery system for immunotherapy of Kirsten rat sarcoma viral oncogene homolog-mutant cancer.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 21, 2025
Selective Targeting of Tip Endothelial Cells as a Therapeutic Strategy for Tumor Angiogenesis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 15, 2025
Doppel as an early-stage biomarker promoting EMT and dissemination in ovarian cancers.
Journal: International journal of cancer
Published: June 02, 2025
Horizontal blocking of metastatic growth factors signaling by low molecular weight heparin derivative to control ovarian cancer progression.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 23, 2025
Microfluidic captured patient-derived circulating endothelial cells identify novel targets of pulmonary arterial hypertension.
Journal: Biomaterials
Published: December 09, 2024
Enhancing the bystander effect of antibody-drug conjugate by using a novel caspase-3 cleavable peptide linker to overcome tumor heterogeneity.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 18, 2024
The prion-like protein Doppel: A soluble biomarker steering ovarian cancer's peritoneal to circulatory dissemination.
Journal: bioRxiv : the preprint server for biology
Published: August 30, 2024
An oral liraglutide nanomicelle formulation conferring reduced insulin-resistance and long-term hypoglycemic and lipid metabolic benefits.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 19, 2024
Macropinocytosis-targeted peptide-docetaxel conjugate for bystander pancreatic cancer treatment.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: May 22, 2024
Synergistic anticancer immunity in metastatic triple-negative breast cancer through an in situ amplifying Peptide-Drug Conjugate.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 25, 2024
Stimulating macropinocytosis of peptide-drug conjugates through DNA-dependent protein kinase inhibition for treating KRAS-mutant cancer.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 09, 2024
Last Updated: 09/26/2026